Latest Optic nerve Stories
FREMONT, Calif., Oct. 20 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a pharmaceutical company engaged in the discovery and development of RNAi-based therapeutics, today announced it has dosed the first patient with recent onset of non-arteritic anterior ischemic optic neuropathy (NAION) in its ongoing Phase I study of QPI-1007, the Company's proprietary synthetic siRNA drug candidate for ocular neuroprotection. The Phase I open-label, dose-escalation study was initiated during the first...
REYKJAVIK, Iceland, September 13, 2010 /PRNewswire-FirstCall/ -- - SNP on Chromosome 7 is Rare Among Chinese but Confers Five-Fold Increase in Risk; Underscores Importance of Analyzing Risk Factors Across Continental Ancestries Scientists at deCODE genetics and academic colleagues from Iceland, China, Sweden, the UK and Australia today report the discovery of the most important single-letter variation (SNP) in the sequence of the human genome yet associated with risk of...
This month's Ophthalmology journal includes surprising research from the Massachusetts Eye and Ear Infirmary on the relation of body weight to the risk for glaucoma. Also, from researchers at the Tokyo Medical and Dental University, comes the first specific map of how the development of myopic maculopathy, an illness that afflicts many severely nearsighted people, predicts which patients will be most susceptible to vision loss.Does Higher Body Weight Protect Women from One Type of...
A quick, painless eye measurement shows promise as a way to diagnose multiple sclerosis in its very early stages, and to track the effectiveness of treatments, researchers from UT Southwestern Medical Center have found in a multicenter study."This technique has the potential to provide a powerful and reliable assessment strategy to measure structural changes in the central nervous system, both for diagnostic purposes and in clinical trials to monitor whether potential treatments can...
Scientists are reporting progress toward a test that could revolutionize the diagnosis of glaucoma "” the second leading cause of vision loss and blindness worldwide "” by detecting the disease years earlier than usually happens at present. They reported the findings yesterday at the 239th National Meeting of the American Chemical Society (ACS)."We are confident that we're moving toward a breakthrough that will allow us to detect glaucoma at its earliest stage," said Chenxu Yu,...
Researchers at the Vanderbilt Eye Institute are now a step closer to deciphering a leading cause of blindness in the United States "“ glaucoma.In a recent study, David Calkins, Ph.D., director of Research at the VEI, discovered that the first sign of injury in glaucoma actually occurs in the brain.Glaucoma is generally considered a disease of the eye in which sensitivity to ocular pressure causes damage to the retina and optic nerve, which are components of the central nervous system and do...
The laboratory of Dr. Frédéric Charron, in Montreal, made this discoveryThe laboratory of Dr. Frédéric Charron, a researcher at the Institut de recherches cliniques de Montréal (IRCM), has discovered a new molecular mechanism that permits the guidance of visual nerves towards the brain. Their findings have been published in the current issue of the Journal of Neuroscience. The research was conducted in collaboration with Dr. Tomomi Shimogori from the RIKEN Brain Science...
The development of a bionic eye that will restore vision to someone who is completely blind is a step closer after the research team working on the project detected signals in the brain from electrodes implanted in the retina of a living eye.The project, led by Associate Professor Michael Ibbotson from The Vision Centre and The Australian National University, has been investigating how artificial electrical signals can be converted into meaningful biological signals in the eye. It uses a...
Mouse study suggests that response to injury-induced growth factors can be revivedBrain and spinal-cord injuries typically leave people with permanent impairment because the injured nerve fibers (axons) cannot regrow. A study from Children's Hospital Boston, published in the December 10 issue of the journal Neuron, shows that axons can regenerate vigorously in a mouse model when a gene that suppresses natural growth factors is deleted.Adding to a previous study published in Science last year,...
Oct. 27 scientific program highlights, AAO-PAAO 2009 MeetingToday's Scientific Program, 2009 American Academy of Ophthalmology (AAO) - Pan-American Association of Ophthalmology (PAAO) Joint Meeting, includes a Veterans Administration study that indicates that Iraq and Afghanistan veterans with vision loss from traumatic brain injury have significantly poorer quality of life than comparable civilian patients, and a Harvard doctor's insights on how to best evaluate and care for low-vision...
